Blog

Peanut-Specific IgE May Help Predict ADRs With Peanut Oral Immunotherapy – Monthly Prescribing Reference (registration)

Peanut-Specific IgE May Help Predict ADRs With Peanut Oral Immunotherapy
Monthly Prescribing Reference (registration)
ATLANTA, GA—An assessment of predictive factors for systemic allergic reactions (SAR) determined that peanut oral immunotherapy (OIT) is safe in patients with peanut allergy (PA), according to the results of a retrospective chart review presented at

2017-03-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.